ACON Infectious Mononucleosis Rapid Tests Receive CLIA Waiver
go back to news archivesThe U.S. FDA have granted a CLIA Waiver for the Whole Blood procedure of ACON Labs Infectious Mononucleosis Rapid Tests, available in both strip and device formats. The CLIA Waiver for the Whole Blood procedure indicates that the tests are simple enough to be used by non-laboratory trained personnel in more than 100,000 physician offices and laboratories in the USA.
The tests give results in just 5 minutes. Clinical studies demonstrated positive agreement of 97%, negative agreement of greater than 99%, and overall agreement of 99% for all specimen types combined versus a leading slide agglutination method.
Infectious Mononucleosis is caused by the Epstein-Barr virus (EBV), one of the most common human viruses. Early and rapid detection is an important first step toward treatment and avoidance of potentially serious complications
Source : ACON Laboratories, Inc. View Company Information
Posted on October 10, 2005
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025